Steven K. Galson, Director of Biocryst Pharmaceuticals BCRX, has filed 1 purchase and 0 sales on the open market. The latest trade was on 06/11.

SG

SG

Steven K. Galson

Director

Company

Biocryst Pharmaceuticals BCRX

First filing

23/06/15

Trades

9 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

06/11

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Biocryst PharmaceuticalsBCRX	Open-market buy	24/05/13	24/05/15	21,940 sh	$5.49	$120,450.6	+74.1%